UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Apple
AAPL
|
+$615M |
| 3 |
NVIDIA
NVDA
|
+$609M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.07B |
| 2 |
Tesla
TSLA
|
+$467M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$262M |
| 4 |
Match Group
MTCH
|
+$241M |
| 5 |
Valero Energy
VLO
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 6.45% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Corcept Therapeutics
CORT
$12B
| $8.25M | ﹤0.01% |
178,196
+11,819
| +7% | +$420K |
|
2552
Steven Madden
SHOO
$3.55B
| $8.23M | ﹤0.01% |
168,063
+41,077
| +32% | +$1.82M |
|
2553
Invesco Advantage Municipal Income Trust II
VKI
$401M
| $8.23M | ﹤0.01% |
883,999
+41,936
| +5% | +$380K |
|
|
ETV
2554
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.76B
| $8.23M | ﹤0.01% |
596,183
+31,388
| +6% | +$422K |
|
2555
Sixth Street Specialty
TSLX
$1.81B
| $8.23M | ﹤0.01% |
400,731
-57,170
| -12% | -$1.2M |
|
2556
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.14B
| $8.22M | ﹤0.01% |
160,499
+9,680
| +6% | +$462K |
|
2557
Indivior Pharmaceuticals
INDV
$4.58B
| $8.21M | ﹤0.01% |
842,131
-957,453
| -53% | -$11.2M |
|
2558
Barings BDC
BBDC
$965M
| $8.2M | ﹤0.01% |
836,659
-293,981
| -26% | -$2.92M |
|
2559
Encompass Health
EHC
$12.4B
| $8.19M | ﹤0.01% |
84,716
-13,085
| -13% | -$1.18M |
|
2560
Mine Safety
MSA
$7.49B
| $8.17M | ﹤0.01% |
46,088
+695
| +2% | +$126K |
|
|
RNAM
2561
DELISTED
Avidity Biosciences
RNAM
| $8.17M | ﹤0.01% |
177,876
+73,493
| +70% | +$3.19M |
|
|
CFLT
2562
PUT
DELISTED
Confluent
CFLT
| $8.15M | ﹤0.01% |
400,000
-100,000
| -20% | -$2.24M |
|
2563
AdvisorShares Ranger Equity Bear ETF
HDGE
$53.4M
| $8.15M | ﹤0.01% |
435,853
+341,038
| +360% | +$6.65M |
|
|
NAPA
2564
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $8.12M | ﹤0.01% |
1,397,029
+1,335,086
| +2,155% | +$8.78M |
|
2565
Brink's
BCO
$4.62B
| $8.11M | ﹤0.01% |
70,137
+10,845
| +18% | +$1.15M |
|
2566
Sabra Healthcare REIT
SBRA
$5.37B
| $8.11M | ﹤0.01% |
435,763
+122,792
| +39% | +$2.07M |
|
2567
iShares US Healthcare Providers ETF
IHF
$1.27B
| $8.1M | ﹤0.01% |
141,841
+13,962
| +11% | +$779K |
|
2568
Addus HomeCare
ADUS
$2.23B
| $8.1M | ﹤0.01% |
60,855
+9,974
| +20% | +$1.26M |
|
2569
Nuveen Floating Rate Income Fund
JFR
$1.25B
| $8.09M | ﹤0.01% |
917,465
-28,136
| -3% | -$247K |
|
2570
Schwab Fundamental International Small Company Index ETF
FNDC
$3.16B
| $8.09M | ﹤0.01% |
212,020
-1,307
| -0.6% | -$47.3K |
|
2571
Hamilton Lane
HLNE
$5.57B
| $8.08M | ﹤0.01% |
47,973
+22,086
| +85% | +$3.2M |
|
2572
iShares MSCI Italy ETF
EWI
$1.07B
| $8.06M | ﹤0.01% |
206,872
-27,021
| -12% | -$1.01M |
|
|
JHG
2573
DELISTED
Janus Henderson
JHG
| $8.06M | ﹤0.01% |
211,671
+90,533
| +75% | +$3.27M |
|
2574
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $8.06M | ﹤0.01% |
339,118
+1,482
| +0.4% | +$34.7K |
|
2575
Karat Packaging
KRT
$940M
| $8.05M | ﹤0.01% |
311,104
+9,200
| +3% | +$247K |
|
Similar funds
UBS Group's Q3 2024 Portfolio in Review
As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.
- UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
- UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
- UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
- UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
- UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.